Van den Elsen PJ - Search Results

1

Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.

Peijnenburg A, Van den Berg R, Van Eggermond MJ, Sanal O, Vossen JM, Lennon AM, Alcaïde-Loridan C, Van den Elsen PJ. Peijnenburg A, et al. Among authors: van eggermond mj, van den elsen pj, van den berg r. Immunogenetics. 2000 Jan;51(1):42-9. doi: 10.1007/s002510050007. Immunogenetics. 2000. PMID: 10663561

2

The RAG cell line defines a new complementation group of MHC class II deficiency.

Lennon A, Ottone C, Peijnenburg A, Hamon-Benais C, Colland F, Gobin S, van den Elsen P, Fellous M, Bono R, Alcaïde-Loridan C. Lennon A, et al. Immunogenetics. 1996;43(6):352-9. doi: 10.1007/BF02199803. Immunogenetics. 1996. PMID: 8606055

3

Definition of a novel complementation group in MHC class II deficiency.

Peijnenburg A, Godthelp B, van Boxel-Dezaire A, van den Elsen PJ. Peijnenburg A, et al. Among authors: van boxel dezaire a, van den elsen pj. Immunogenetics. 1995;41(5):287-94. doi: 10.1007/BF00172153. Immunogenetics. 1995. PMID: 7721350

4

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA.

Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen PJ. Gobin SJ, et al. Among authors: van den elsen pj. Immunity. 1997 May;6(5):601-11. doi: 10.1016/s1074-7613(00)80348-9. Immunity. 1997. PMID: 9175838 Free article.

5

Regulation of MHC class I and II gene transcription: differences and similarities.

van den Elsen PJ, Gobin SJ, van Eggermond MC, Peijnenburg A. van den Elsen PJ, et al. Among authors: van eggermond mc. Immunogenetics. 1998 Aug;48(3):208-21. doi: 10.1007/s002510050425. Immunogenetics. 1998. PMID: 9683666 Review.

6

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.

Gobin SJ, Peijnenburg A, van Eggermond M, van Zutphen M, van den Berg R, van den Elsen PJ. Gobin SJ, et al. Among authors: van eggermond m, van zutphen m, van den elsen pj, van den berg r. Immunity. 1998 Oct;9(4):531-41. doi: 10.1016/s1074-7613(00)80636-6. Immunity. 1998. PMID: 9806639 Free article.

7

Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene.

Peijnenburg A, Van Eggermond MC, Van den Berg R, Sanal O, Vossen JM, Van den Elsen PJ. Peijnenburg A, et al. Among authors: van den elsen pj, van den berg r, van eggermond mc. Immunogenetics. 1999 Apr;49(4):338-45. doi: 10.1007/s002510050501. Immunogenetics. 1999. PMID: 10079298

8

Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.

Peijnenburg A, Van Eggermond MJ, Gobin SJ, Van den Berg R, Godthelp BC, Vossen JM, Van den Elsen PJ. Peijnenburg A, et al. Among authors: van eggermond mj, van den elsen pj, van den berg r. J Immunol. 1999 Jul 15;163(2):794-801. J Immunol. 1999. PMID: 10395672

9

TCR V alpha- and V beta-gene segment use in T-cell subcultures derived from a type-III bare lymphocyte syndrome patient deficient in MHC class-II expression.

Lambert M, Van Eggermond M, Mascart F, Dupont E, Van den Elsen P. Lambert M, et al. Dev Immunol. 1992;2(3):227-36. doi: 10.1155/1992/29814. Dev Immunol. 1992. PMID: 1320968 Free PMC article.

10

Analysis of the peripheral T-cell compartment in the MHC class II deficiency syndrome.

Lambert M, van Eggermond M, Andrien M, Mascart F, Vamos E, Dupont E, van den Elsen P. Lambert M, et al. Res Immunol. 1991 Nov-Dec;142(9):789-98. doi: 10.1016/0923-2494(91)90124-2. Res Immunol. 1991. PMID: 1796210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page